This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock CHFS vs. QTI, NRXS, VRAYQ, VIVE, ELMD, AVTX, ZNTL, SERA, TARA, and FATEShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), Avalo Therapeutics (AVTX), Zentalis Pharmaceuticals (ZNTL), Sera Prognostics (SERA), Protara Therapeutics (TARA), and Fate Therapeutics (FATE). These companies are all part of the "medical" sector. Nuwellis vs. Its Competitors QT Imaging NeurAxis ViewRay Viveve Medical Electromed Avalo Therapeutics Zentalis Pharmaceuticals Sera Prognostics Protara Therapeutics Fate Therapeutics Nuwellis (NASDAQ:CHFS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability. Do institutionals & insiders believe in CHFS or QTI? 65.1% of Nuwellis shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 0.6% of Nuwellis shares are held by company insiders. Comparatively, 75.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, CHFS or QTI? Nuwellis has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500. Is CHFS or QTI more profitable? QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% QT Imaging N/A N/A -65.94% Does the media refer more to CHFS or QTI? In the previous week, Nuwellis had 1 more articles in the media than QT Imaging. MarketBeat recorded 1 mentions for Nuwellis and 0 mentions for QT Imaging. Nuwellis' average media sentiment score of 0.00 equaled QT Imaging'saverage media sentiment score. Company Overall Sentiment Nuwellis Neutral QT Imaging Neutral Which has higher earnings & valuation, CHFS or QTI? QT Imaging has lower revenue, but higher earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M4.58-$18.11M-$279.28-0.01QT Imaging$4.00M17.31-$4.03MN/AN/A SummaryQT Imaging beats Nuwellis on 6 of the 10 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.24M$47.50M$5.85B$10.14BDividend YieldN/AN/A5.68%4.60%P/E Ratio-0.083.9975.4125.98Price / Sales4.58221.23514.54181.13Price / CashN/A41.3637.5660.44Price / Book0.332.4512.156.29Net Income-$18.11M-$2.66M$3.29B$271.07M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$4.18-0.7%N/A+272.6%$25.24M$5.51M-0.0866QTIQT ImagingN/A$2.52+3.3%N/A+379.4%$68.38M$4.00M0.00N/ANRXSNeurAxis2.2506 of 5 stars$2.63+3.5%$7.00+166.2%-21.8%$25.93M$3.22M-1.4319Short Interest ↑VRAYQViewRayN/A$0.00+∞N/AN/A$18K$102.21M0.00300High Trading VolumeVIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070ELMDElectromed3.9629 of 5 stars$23.95-3.2%$36.25+51.4%+31.0%$206.48M$64M31.93160News CoverageInsider TradeAVTXAvalo Therapeutics3.7873 of 5 stars$9.02-2.9%$30.00+232.6%+18.5%$122.18M$440K0.0040Short Interest ↓ZNTLZentalis Pharmaceuticals1.8703 of 5 stars$1.72+1.8%$8.20+376.7%-52.7%$121.91M$67.43M-0.76160Positive NewsSERASera Prognostics1.095 of 5 stars$3.33+3.1%N/A-57.5%$121.68M$80K-3.92120News CoverageTARAProtara Therapeutics1.5513 of 5 stars$3.17+1.6%$19.60+518.3%+81.5%$120.38MN/A-1.9630Positive NewsFATEFate Therapeutics4.0359 of 5 stars$1.03-1.0%$3.30+220.4%-74.2%$119.94M$13.63M-0.71550Positive News Related Companies and Tools Related Companies QTI Alternatives NRXS Alternatives VRAYQ Alternatives VIVE Alternatives ELMD Alternatives AVTX Alternatives ZNTL Alternatives SERA Alternatives TARA Alternatives FATE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHFS) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.